We are live on
!
Find out more
BCM
Brown Capital Management Portfolio holdings
AUM
$500M
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
+12.55%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$6.69B
AUM Growth
+$645M
(+11%)
Cap. Flow
+$93.3M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
44.19%
Holding
131
New
3
Increased
41
Reduced
62
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$75.7M |
| 2 |
Vicor
VICR
|
+$68.8M |
| 3 |
Xometry
XMTR
|
+$54M |
| 4 |
Workiva
WK
|
+$37.9M |
| 5 |
Cytek Biosciences
CTKB
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DCT
Duck Creek Technologies, Inc. Common Stock
DCT
|
+$55M |
| 2 |
Manhattan Associates
MANH
|
+$52.1M |
| 3 |
Cognex
CGNX
|
+$42.1M |
| 4 |
QuidelOrtho
QDEL
|
+$32.5M |
| 5 |
Tyler Technologies
TYL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 58.66% |
| 2 | Healthcare | 31.96% |
| 3 | Industrials | 7.42% |
| 4 | Consumer Discretionary | 0.97% |
| 5 | Materials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
1
DELISTED
Ansys
ANSS
| $341M | 5.1% |
1,024,450
-42,948
| -4% | -$12.1M |
|
2
AppFolio
APPF
$7.59B
| $337M | 5.04% |
2,708,557
-92,118
| -3% | -$11.1M |
|
|
3
Manhattan Associates
MANH
$12.5B
| $324M | 4.85% |
2,094,098
-378,233
| -15% | -$52.1M |
|
4
Veeva Systems
VEEV
$44.5B
| $300M | 4.49% |
1,634,651
-23,332
| -1% | -$3.98M |
|
5
Paycom
PAYC
$10.4B
| $298M | 4.45% |
979,019
-9,226
| -0.9% | -$2.78M |
|
|
SMAR
6
DELISTED
Smartsheet Inc.
SMAR
| $288M | 4.3% |
6,020,120
-47,277
| -0.8% | -$2.06M |
|
|
7
Tyler Technologies
TYL
$14.9B
| $287M | 4.29% |
808,995
-62,138
| -7% | -$20.2M |
|
8
Datadog
DDOG
$76.5B
| $262M | 3.92% |
3,604,833
+193,407
| +6% | +$14.2M |
|
9
Alarm.com
ALRM
$2.77B
| $260M | 3.89% |
5,173,049
-42,193
| -0.8% | -$2.17M |
|
|
10
Cognex
CGNX
$10.5B
| $259M | 3.87% |
5,231,583
-831,036
| -14% | -$42.1M |
|
11
Guidewire Software
GWRE
$13.5B
| $248M | 3.71% |
3,025,129
-20,679
| -0.7% | -$1.5M |
|
12
Repligen
RGEN
$9.46B
| $243M | 3.62% |
1,440,368
-11,967
| -0.8% | -$2.14M |
|
13
Bio-Techne
TECH
$11.4B
| $242M | 3.62% |
3,262,377
-39,115
| -1% | -$3.01M |
|
14
Vericel Corp
VCEL
$2.06B
| $206M | 3.09% |
7,042,113
+110,472
| +2% | +$3.2M |
|
15
Helios Technologies
HLIO
$2.36B
| $195M | 2.91% |
2,976,561
-17,394
| -0.6% | -$1.13M |
|
16
CryoPort
CYRX
$801M
| $180M | 2.69% |
7,489,089
+529,882
| +8% | +$11.5M |
|
|
17
10x Genomics
TXG
$8.16B
| $172M | 2.56% |
3,075,589
+1,621,959
| +112% | +$75.7M |
|
|
CYBR
18
DELISTED
CyberArk
CYBR
| $150M | 2.24% |
1,014,854
-43,759
| -4% | -$6.12M |
|
19
OrthoPediatrics
KIDS
$585M
| $146M | 2.18% |
3,295,207
+119,214
| +4% | +$5.27M |
|
20
Glaukos
GKOS
$10.5B
| $146M | 2.18% |
2,904,658
+191,849
| +7% | +$9.31M |
|
|
ABCM
21
DELISTED
Abcam PLC
ABCM
| $131M | 1.96% |
9,751,719
-149,889
| -2% | -$2.24M |
|
|
PRO
22
DELISTED
PROS Holdings
PRO
| $124M | 1.86% |
4,539,649
-221,896
| -5% | -$5.78M |
|
|
OLO
23
DELISTED
Olo Inc
OLO
| $122M | 1.82% |
14,892,722
+1,727,645
| +13% | +$13.3M |
|
24
Neogen
NEOG
$2.58B
| $108M | 1.62% |
5,845,603
-782,073
| -12% | -$14.7M |
|
25
nCino
NCNO
$2.44B
| $104M | 1.56% |
4,208,519
+290,237
| +7% | +$7.65M |
|
Similar funds
HC
TLP
ISWM
PT
FGWP
PCA
FNBOMD
TPWM
Brown Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Brown Capital Management held 131 positions worth $6.69B, up 11% from $6.05B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Brown Capital Management's Q1 2023 filing shows 3 new, 41 increased, 62 reduced and 7 closed positions. Its largest new stake was Inari Medical, Inc. Common Stock: 496,918 shares worth $30.7M. The largest sale was Duck Creek Technologies, Inc. Common Stock, an estimated $55M.
By sector, the portfolio is most concentrated in Technology at 59% of assets, down from 59% a quarter earlier, followed by Healthcare and Industrials.
- Brown Capital Management's largest Q1 2023 buy was Inari Medical, Inc. Common Stock: 496,918 shares worth $30.7M.
- Brown Capital Management added most to 10x Genomics in Q1 2023, an estimated $75.7M increase.
- Brown Capital Management's biggest Q1 2023 reduction was Manhattan Associates, cutting an estimated $52.1M.
- Brown Capital Management fully exited Duck Creek Technologies, Inc. Common Stock in Q1 2023, selling an estimated $55M.
- Brown Capital Management's ten largest holdings make up 44% of its $6.69B portfolio in Q1 2023.
- Brown Capital Management opened 3 new positions and closed 7 in Q1 2023.
- Brown Capital Management's portfolio value rose 11% quarter-over-quarter to $6.69B.
Based on Brown Capital Management's 13F filing for Q1 2023, filed 15 May 2023.